Do you know the different ECLS/ECMO therapy options?
Many CVD patients experience cardiogenic shock, a frequent consequence of a heart attack, because the heart muscle is not adequately supplied with oxygen. Other conditions that can lead to failure of the heart and/or lungs include acute respiratory distress syndrome (ARDS), severe influenza (e.g., H1N1), septic shock and pulmonary embolism. Patients with serious cardiac and/or pulmonary compromise require immediate stabilization and perhaps inter-hospital transfer.
Extracorporeal life support (ECLS), or extracorporeal membrane oxygenation (ECMO), has become a standard therapy option to stabilize blood circulation and/or respiratory functions of affected patients.
ECLS therapy to prevent organ damage
ECLS or ECMO can be used to temporarily support heart and/or lung function (partially or totally) during cardiopulmonary failure, leading to organ recovery or replacement. Veno-arterial life support is used with patients whose hearts are not adequately supporting their circulation or have arrested, which may occur with a myocardial infarction. Veno-venous life support provides respiratory assistance for lung disorders, and is primarily used when the heart is still able to pump blood through the circulatory system without any additional support.
Reduction of blood CO₂
Facilitating protective ventilation strategies, even in severe cases of acute respiratory failure
The veno-venous use of the CARDIOHELP System ensures an effective oxygen supply and/or the reduction of blood CO2 level in intensive care patients suffering from ARDS, sepsis or other indications associated with acute respiratory failure.
Did you know that ECLS could be a life saver for ARDS patients?
Severe acute respiratory distress syndrome (ARDS) continues to have still has a high mortality rate. Extracorporeal life support (ECLS) can be a good therapy option when standard therapies fail. The use of ECLS for adult ARDS has increased over the last decade. More and more specialized centers use perform ECLS today, and there are many reports available that confirm that ECLS therapies deliver improved outcomes for adult ARDS patients.
With its CARDIOHELP System, Getinge makes available a portable heart-lung support system providing mechanical extracorporeal assist to replace or support a patient's blood circulation and/or gas exchange.
1. World Health Organization, Global status report on non-communicable diseases 2014.